Annie Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Annie Ma has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
A. John Iafrate
Massachusetts General Hospital, Boston, MA
1 shared publication- Aditya Bardia
University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, USA
1 shared publication - Alexander Agadjanian
MIT Election and Data Science Lab
1 shared publication Alexander Hurt
Dartmouth College, Hanover, NH, USA
1 shared publicationAlexander Wasdahl
Dartmouth College, Hanover, NH, USA
1 shared publicationAlexandra Woodruff
Dartmouth College, Hanover, NH, USA
1 shared publication
Latest Publications
- 1 January 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 20 (1) , 69-76
Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration
PURPOSEThere is a demand for improved care delivery surrounding genomic testing and clinical trial enrollment among patients with metastatic breast cancer (MBC). We sought to improve the current process via real-time informal consultation and prescreening assessment for patients with MBC treated by community and academic medical oncologists by implementing a virtual molecular and precision medicine (vMAP) clinic.METHODSThe vMAP program used a virtual referral system directed to a multidisciplinary team with precision medicine expertise. Providers contacted vMAP regarding patients with MBC, and on receipt of referral, the vMAP team engaged in discussion to identify if further diagnostics were needed (including genomic testing) and to identify potential clinical trials or standard treatment options. Recommendations were then sent to the referring provider within 72 hours. Pre-/postsurveys were issued to network physicians to assess for barriers, clinical trial access, and vMAP referral experience. Program implementation was evaluated with the Squire 2.0 reporting guidelines for quality improvement in health care as a framework.RESULTSEighty-one cases from 22 providers were referred to vMAP over a 26-month period. The average response time to the referring provider with a finalized recommendation was 1.90 +/- 1.82 days. A total of 86.4% of cases had clinical trial options on vMAP prescreen, with 40.7% initiating formal screening assessments and 27 patients (33.3%) ultimately enrolling on trials. On resurvey, 92% of survey responses across community oncology referring providers said that they were very likely to use vMAP again.CONCLUSIONIn the initial 2-year period, vMAP demonstrated an efficient means to offer real-time interpretation of genomic testing and identification of clinical trials for patients with MBC, with effective clinical trial enrollment and high rates of referring provider satisfaction. A virtual referral system is a flexible way to streamline precision medicine care delivery for patients with MBC.
- 1 January 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 20 (1) , 69-76
Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration
PURPOSEThere is a demand for improved care delivery surrounding genomic testing and clinical trial enrollment among patients with metastatic breast cancer (MBC). We sought to improve the current process via real-time informal consultation and prescreening assessment for patients with MBC treated by community and academic medical oncologists by implementing a virtual molecular and precision medicine (vMAP) clinic.METHODSThe vMAP program used a virtual referral system directed to a multidisciplinary team with precision medicine expertise. Providers contacted vMAP regarding patients with MBC, and on receipt of referral, the vMAP team engaged in discussion to identify if further diagnostics were needed (including genomic testing) and to identify potential clinical trials or standard treatment options. Recommendations were then sent to the referring provider within 72 hours. Pre-/postsurveys were issued to network physicians to assess for barriers, clinical trial access, and vMAP referral experience. Program implementation was evaluated with the Squire 2.0 reporting guidelines for quality improvement in health care as a framework.RESULTSEighty-one cases from 22 providers were referred to vMAP over a 26-month period. The average response time to the referring provider with a finalized recommendation was 1.90 +/- 1.82 days. A total of 86.4% of cases had clinical trial options on vMAP prescreen, with 40.7% initiating formal screening assessments and 27 patients (33.3%) ultimately enrolling on trials. On resurvey, 92% of survey responses across community oncology referring providers said that they were very likely to use vMAP again.CONCLUSIONIn the initial 2-year period, vMAP demonstrated an efficient means to offer real-time interpretation of genomic testing and identification of clinical trials for patients with MBC, with effective clinical trial enrollment and high rates of referring provider satisfaction. A virtual referral system is a flexible way to streamline precision medicine care delivery for patients with MBC.
- Open Access
- 1 July 2019
- Published by SAGE Publications in Research & Politics
- Vol. 6 (3)
Counting the Pinocchios: The effect of summary fact-checking data on perceived accuracy and favorability of politicians
Can the media effectively hold politicians accountable for making false claims? Journalistic fact-checking assesses the accuracy of individual public statements by public officials, but less is known about whether this process effectively imposes reputational costs on misinformation-prone politicians who repeatedly make false claims. This study therefore explores the effects of exposure to summaries of fact-check ratings, a new format that presents a more comprehensive assessment of politician statement accuracy over time. Across three survey experiments, we compared the effects of negative individual statement ratings and summary fact-checking data on favorability and perceived statement accuracy of two prominent elected officials. As predicted, summary fact-checking had a greater effect on politician perceptions than individual fact-checking. Notably, we did not observe the expected pattern of motivated reasoning: co-partisans were not consistently more resistant than supporters of the opposition party. Our findings suggest that summary fact-checking is particularly effective at holding politicians accountable for misstatements.
- 1 July 2019
- Published by SAGE Publications in Research & Politics
- Vol. 6 (3)
Open AccessCounting the Pinocchios: The effect of summary fact-checking data on perceived accuracy and favorability of politicians
Can the media effectively hold politicians accountable for making false claims? Journalistic fact-checking assesses the accuracy of individual public statements by public officials, but less is known about whether this process effectively imposes reputational costs on misinformation-prone politicians who repeatedly make false claims. This study therefore explores the effects of exposure to summaries of fact-check ratings, a new format that presents a more comprehensive assessment of politician statement accuracy over time. Across three survey experiments, we compared the effects of negative individual statement ratings and summary fact-checking data on favorability and perceived statement accuracy of two prominent elected officials. As predicted, summary fact-checking had a greater effect on politician perceptions than individual fact-checking. Notably, we did not observe the expected pattern of motivated reasoning: co-partisans were not consistently more resistant than supporters of the opposition party. Our findings suggest that summary fact-checking is particularly effective at holding politicians accountable for misstatements.